Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Psychiatry

Sec. Sleep Disorders

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1612230

This article is part of the Research TopicThe Advance on Sleep Disorder: Mechanisms and InterventionsView all 15 articles

Esketamine for Postoperative Sleep Disturbance: Clinical Evidence, Mechanisms, and Future Directions

Provisionally accepted
  • 1Lanzhou University, Lanzhou, Gansu Province, China
  • 2First Hospital of Lanzhou University, Lanzhou, Gansu Province, China

The final, formatted version of the article will be published soon.

Postoperative sleep disturbance (PSD) is a common complication following surgery. Numerous factors can contribute to PSD, including personal factors, intraoperative factors, postoperative complications and environmental factors. PSD can lead to a range of adverse outcomes, severely impairing patients' postoperative recovery and long-term prognosis. Esketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist and the dextrorotatory isomer of ketamine, which has stronger receptor affinity, more significant analgesic effects and better safety than ketamine. In recent years, in addition to the proven sedative, analgesic and antidepressant properties, emerging evidence highlights that esketamine may improve PSD through a variety of mechanisms, but the existing research results are still controversial. This article reviews the latest research progress of esketamine in improving PSD, and discusses its clinical efficacy and potential mechanism of action, in order to provide theoretical basis and practical guidance for optimizing perioperative anesthesia management and promoting postoperative rehabilitation of patients.

Keywords: Postoperative sleep disturbance, sleep quality, Esketamine, Ketamine, NMDA receptor antagonist

Received: 15 Apr 2025; Accepted: 23 Oct 2025.

Copyright: © 2025 Liu, Liu, Fu, Gao and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yatao Liu, liuyt@lzu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.